Cholesterol-butyl-biguanide conjugate as a novel excipient enhances the efficacy of doxorubicin liposomes against triple-negative breast cancer by potentiating immunogenic cell death

European Journal of Pharmaceutics and Biopharmaceutics 2026

View at publisher

Authors: yanzhi wang, Lu Li, Yanting Fan, Jiaxin Zheng, Hongmin Liu

DOI: 10.1016/j.ejpb.2026.115093

Cited by: 1

References: 34

Fields of Study & Subjects

Nanoparticle-Based Drug Delivery Cancer Lipids and Metabolism Nanoplatforms for cancer theranostics

References 34